(Q43795633)

26 November 2017

title

Fexofenadine reduces nasal congestion in perennial allergic rhinitis (English)

1 reference

26 November 2017

1 reference

Ciprandi G

1

1 reference

26 November 2017

Cosentino C

2

1 reference

26 November 2017

Milanese M

3

1 reference

26 November 2017

Mondino C

4

1 reference

26 November 2017

Canonica GW

5

1 reference

26 November 2017

publication date

1 November 2001

1 reference

26 November 2017

1 reference

26 November 2017

volume

56

1 reference

26 November 2017

issue

11

1 reference

26 November 2017

page(s)

1068-1070

1 reference

Pathophysiology of perennial allergic rhinitis

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00191.X

Rhinitis and inhalant allergens

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00191.X

Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00191.X

Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00191.X

Eotaxin levels and eosinophils in guinea pig broncho-alveolar lavage fluid are increased at the onset of a viral respiratory infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00191.X

Mizolastine therapy also has an effect on nasal blockade in perennial allergic rhinoconjunctivitis. RIPERAN Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00191.X

Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00191.X

Minimal persistent inflammation is present at mucosal level in patients with asymptomatic rhinitis and mite allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00191.X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1034/J.1398-9995.2001.00191.X

1 reference

26 November 2017

1 reference